BMO Capital Markets Reiterates “Outperform” Rating for Monsanto Co. (MON)
Monsanto Co. (NYSE:MON)‘s stock had its “outperform” rating reaffirmed by analysts at BMO Capital Markets in a research note issued on Saturday. They presently have a $128.00 price target on the stock. BMO Capital Markets’ price target indicates a potential upside of 23.84% from the company’s previous close.
Several other research firms have also recently commented on MON. Piper Jaffray Cos. restated an “overweight” rating and issued a $127.00 price target (up previously from $95.00) on shares of Monsanto in a report on Monday, June 13th. Jefferies Group reaffirmed a “buy” rating on shares of Monsanto in a research note on Tuesday, September 6th. Zacks Investment Research raised Monsanto from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 6th. Monness Crespi & Hardt raised Monsanto from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $106.93 to $130.00 in a research note on Monday, August 8th. Finally, TheStreet lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, September 12th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $114.67.
Shares of Monsanto (NYSE:MON) opened at 103.36 on Friday. The company’s 50 day moving average is $104.86 and its 200-day moving average is $101.43. The stock has a market capitalization of $45.23 billion, a price-to-earnings ratio of 45.49 and a beta of 1.19. Monsanto has a 1-year low of $83.73 and a 1-year high of $114.26.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/08/bmo-capital-markets-reiterates-outperform-rating-for-monsanto-co-mon.html
Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.09. The company earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm’s revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.19) EPS. Equities analysts anticipate that Monsanto will post $4.89 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.09%. Monsanto’s payout ratio is 71.05%.
In other news, CEO Michael K. Stern sold 12,797 shares of the stock in a transaction on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the transaction, the chief executive officer now owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is owned by insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. WFG Advisors LP boosted its position in Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock valued at $104,000 after buying an additional 158 shares during the last quarter. Signaturefd LLC boosted its position in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares during the last quarter. Mycio Wealth Partners LLC raised its stake in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares during the period. Pinkerton Retirement Specialists LLC raised its stake in shares of Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock valued at $114,000 after buying an additional 1,014 shares during the period. Finally, Carnick & Kubik LLC purchased a new stake in shares of Monsanto during the first quarter valued at $130,000. 79.02% of the stock is owned by institutional investors.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.